The use of high dose aprotinin in liver transplantation: The influence on fibrinolysis and blood loss
Authors:
- W. LobbesWLW. Lobbes
- M. FrambachMFM. Frambach
- O. von BroenOBO. von Broen
- B. RingeBRB. Ringe
- M. BarthelsMBM. Barthels
- 1 August 1991
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 63 (3) , 287-297
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Human plasma extrinsic pathway inhibitor activity: II. Plasma levels in disseminated intravascular coagulation and hepatocellular diseaseBlood, 1989
- SYSTEMIC EFFECTS OF TISSUE PLASMINOGEN ACTIVATOR-ASSOCIATED FIBRINOLYSIS AND ITS RELATION TO THROMBIN GENERATION IN ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 1989
- Reduction of Blood Transfusion Requirement in Open Heart Surgery by Administration of High Doses of Aprotinin - Preliminary ResultsThe Thoracic and Cardiovascular Surgeon, 1989
- Fibrinolysis during liver transplantation in humans: role of tissue- type plasminogen activatorBlood, 1988
- EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERYThe Lancet, 1987
- The pathogenesis of accelerated fibrinolysis in liver cirrhosis: a critical role for tissue plasminogen activator inhibitorBlood, 1987
- Hemostasis and Fibrinolysis in Severe Liver Failure and Their Relation to HemorrhageHepatology, 1986
- The Coagulation Disorder of Orthotopic Hepatic TransplantationSeminars in Thrombosis and Hemostasis, 1977
- Liver Transplantation in Man—IV, Haemorrhage and ThrombosisBMJ, 1969
- Coagulation During and After Orthotopic Transplantation of the Human LiverArchives of Surgery, 1969